Cargando…

A novel approach to overcome drug resistance in acute myeloid leukemia

Detalles Bibliográficos
Autores principales:	Mazewski, Candice, Platanias, Leonidas C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Fondazione Ferrata Storti 2023
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620585/ https://www.ncbi.nlm.nih.gov/pubmed/37165841 http://dx.doi.org/10.3324/haematol.2023.283099

Ejemplares similares

MNK Proteins as Therapeutic Targets in Leukemia
por: Mazewski, Candice, et al.
Publicado: (2023)

Role of Biomarkers in the Management of Acute Myeloid Leukemia
por: Small, Sara, et al.
Publicado: (2022)

Type I Interferon (IFN)-Regulated Activation of Canonical and Non-Canonical Signaling Pathways
por: Mazewski, Candice, et al.
Publicado: (2020)

An integrative systems biology approach to overcome venetoclax resistance in acute myeloid leukemia
por: Przedborski, Michelle, et al.
Publicado: (2022)

Genetic Landscape of Chronic Myeloid Leukemia and a Novel Targeted Drug for Overcoming Resistance
por: Yoshimaru, Ryo, et al.
Publicado: (2023)

Inhibitory effects of Tomivosertib in acute myeloid leukemia
por: Suarez, Milagros, et al.
Publicado: (2021)

A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia
por: Wang, Peihong, et al.
Publicado: (2021)

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia
por: Gleixner, Karoline V., et al.
Publicado: (2017)

Overcoming treatment resistance in acute promyelocytic leukemia and beyond
por: Fung, Tsz Kan, et al.
Publicado: (2013)

Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
por: Sharma, Priyanka, et al.
Publicado: (2023)

Targeting GLUT1 in acute myeloid leukemia to overcome cytarabine resistance
por: Åbacka, Hannah, et al.
Publicado: (2021)

The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia
por: Wang, Hao, et al.
Publicado: (2018)

Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
por: Pan, Xiao-Na, et al.
Publicado: (2014)

An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in MLL1-rearranged acute myeloid leukemia in mice
por: Wang, Hao, et al.
Publicado: (2020)

Venetoclax Overcomes Sorafenib Resistance in Acute Myeloid Leukemia by Targeting BCL2
por: Xu, Xi, et al.
Publicado: (2023)

Inhibitory effects of SEL201 in acute myeloid leukemia
por: Kosciuczuk, Ewa M., et al.
Publicado: (2019)

GNF-7, a novel FLT3 inhibitor, overcomes drug resistance for the treatment of FLT3‑ITD acute myeloid leukemia
por: Xiao, Xinhua, et al.
Publicado: (2023)

Antifungal Prophylaxis in Acute Myeloid Leukemia: New Drugs, New Challenges?: Summary of the EHA Guideline on Antifungal Prophylaxis in Adult Patients With Acute Myeloid Leukemia Treated With Novel-targeted Therapies
por: Stemler, Jannik, et al.
Publicado: (2022)

Combination strategies to overcome drug resistance in FLT(+) acute myeloid leukaemia
por: Yang, Jingmei, et al.
Publicado: (2023)

ULK1 in type I interferon response
por: Saleiro, Diana, et al.
Publicado: (2015)

Molecular Classification and Overcoming Therapy Resistance for Acute Myeloid Leukemia with Adverse Genetic Factors
por: Ikeda, Daisuke, et al.
Publicado: (2022)

Mechanisms of drug resistance in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2019)

Overcoming Resistance to Kinase Inhibitors: The Paradigm of Chronic Myeloid Leukemia
por: De Santis, Sara, et al.
Publicado: (2022)

Innate Immune Mechanisms and Immunotherapy of Myeloid Malignancies
por: Small, Sara, et al.
Publicado: (2021)

Cooperation between AlphavBeta3 integrin and the fibroblast growth factor receptor enhances proliferation of Hox-overexpressing acute myeloid leukemia cells
por: Shah, Chirag A., et al.
Publicado: (2016)

Data mining in acute myeloid leukemia: identification of disease biomarkers, prognostic factors, novel targets, and potential drugs
por: Machado-Neto, João Agostinho, et al.
Publicado: (2023)

Fusion genes in acute myeloid leukemia: do acute myeloid leukemia diagnostics need to fuse with RNA-sequencing?
por: Thol, Felicitas
Publicado: (2022)

Chronic myeloid leukemia versus acute myeloid leukemia in patients with retinoblastoma
por: Leahey, Ann-Marie, et al.
Publicado: (2021)

A Novel Inhibitor of STAT5 Signaling Overcomes Chemotherapy Resistance in Myeloid Leukemia Cells
por: Brachet-Botineau, Marie, et al.
Publicado: (2019)

Novel Approaches for Overcoming Biological Barriers
por: Agrahari, Vibhuti, et al.
Publicado: (2022)

Disulfiram overcomes bortezomib and cytarabine resistance in Down-syndrome-associated acute myeloid leukemia cells
por: Bista, Ranjan, et al.
Publicado: (2017)

Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia
por: Labbozzetta, Manuela, et al.
Publicado: (2022)

AMPK in BCR-ABL expressing leukemias. Regulatory effects and therapeutic implications
por: Vakana, Eliza, et al.
Publicado: (2011)

CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023)

Current treatment for pediatric acute myeloid leukemia
por: Im, Ho Joon
Publicado: (2018)

The Important Role of Immunotherapies in Acute Myeloid Leukemia
por: Greiner, Jochen
Publicado: (2019)

Pulling the Pin on NPMc(+) acute myeloid leukemia
por: Kats, Lev M.
Publicado: (2021)

Will immune therapy cure acute myeloid leukemia?
por: Gale, Robert Peter
Publicado: (2019)

Check(point) or checkmate for acute myeloid leukemia?
por: Niyongere, Sandrine, et al.
Publicado: (2021)

Targeting of the leukemia microenvironment by c(RGDfV) overcomes the resistance to chemotherapy in acute myeloid leukemia in biomimetic polystyrene scaffolds
por: Shen, Zhao-Hua, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kbrik5d2g4v29ub49io93qnlvn